Fed. Circ. Nixes Apotex Patent For Inequitable Conduct
The Federal Circuit on Friday affirmed a lower court's ruling that an Apotex Inc. patent on a method of manufacturing drugs used to treat high blood pressure is unenforceable because of...To view the full article, register now.
Already a subscriber? Click here to view full article